Akebia Therapeutics, Inc.

Akebia Therapeutics, Inc. is a biopharmaceutical company specializing in the development and commercialization of therapeutics for kidney diseases. Its lead product, vadadustat, is an oral therapy in Phase III development for treating anemia due to chronic kidney disease in adult patients. The company also offers Auryxia, a ferric citrate used to control serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease, and for treating iron deficiency anemia in adult patients with chronic kidney disease not on dialysis.

Products

• Vadadustat (oral therapy for anemia in chronic kidney disease)

• Auryxia (ferric citrate for controlling serum phosphorus levels and treating iron deficiency anemia)